| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |